The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Automated Immunoblotting Processors Market Research Report 2025
Synopsis
Immunoblotting is an experimental method commonly used in molecular biology, biochemistry and immunogenetics. The basic principle is to stain cells or biological tissue samples processed by gel electrophoresis with specific antibodies. Obtain information on the expression of specific proteins in the cells or tissues analyzed by analyzing the location and depth of staining. The Automated immunoblotting Processor is a quantitative analysis system based on immunoblot analysis.
Global Automated Immunoblotting Processors market is projected to reach US$ 1407.5 million in 2029, increasing from US$ 924.6 million in 2022, with the CAGR of 6.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Automated Immunoblotting Processors market research.
The western blotting market is driven by several factors such as the emergence of new proteomics applications and rising HIV infection rates. Prevalence of chronic diseases and rising expenditure on healthcare research activities are also expected to fuel the demand for western blotting. Several important factors further drive the demand for western blotting such as growing preference for personalized medicine and increasing emphasis on maintaining a healthy lifestyle. Furthermore, the introduction of advanced diagnostic technologies and rising awareness of diseases contributes to the overall expansion of the market. The cost-effective and rapid diagnostic capabilities offered by western blotting systems are expected to further drive the demand for this product. Continued demand from pharmaceutical and biotech companies is driving the growth of Western blot manufacturers. Moreover, the expansion of R&D activities in the field of proteomics is also acting as an additional catalyst for the growth of industrial players in this market. Dynamics of protein research, increasing investments in proteomics by biotech and pharmaceutical companies, and rising prevalence of acquired immunodeficiency syndrome (AIDS) are expected to drive the growth of the industry over the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Automated Immunoblotting Processors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Bio-Techne
Merck
PerkinElmer
Gen Script Biotech
ATTO Corporation
Tecan
Life Technologies
Euroimmun
Precision Biosystems
Cytoskeleton
LI-COR Biosciences
Cytiva
Molecular Devices
Segment by Type
Dry Blotting Systems
Semi-Dry Blotting Systems
Others
Segment by Application
Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Research & Academic Institution
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Automated Immunoblotting Processors report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Immunoblotting is an experimental method commonly used in molecular biology, biochemistry and immunogenetics. The basic principle is to stain cells or biological tissue samples processed by gel electrophoresis with specific antibodies. Obtain information on the expression of specific proteins in the cells or tissues analyzed by analyzing the location and depth of staining. The Automated immunoblotting Processor is a quantitative analysis system based on immunoblot analysis.
Global Automated Immunoblotting Processors market is projected to reach US$ 1407.5 million in 2029, increasing from US$ 924.6 million in 2022, with the CAGR of 6.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Automated Immunoblotting Processors market research.
The western blotting market is driven by several factors such as the emergence of new proteomics applications and rising HIV infection rates. Prevalence of chronic diseases and rising expenditure on healthcare research activities are also expected to fuel the demand for western blotting. Several important factors further drive the demand for western blotting such as growing preference for personalized medicine and increasing emphasis on maintaining a healthy lifestyle. Furthermore, the introduction of advanced diagnostic technologies and rising awareness of diseases contributes to the overall expansion of the market. The cost-effective and rapid diagnostic capabilities offered by western blotting systems are expected to further drive the demand for this product. Continued demand from pharmaceutical and biotech companies is driving the growth of Western blot manufacturers. Moreover, the expansion of R&D activities in the field of proteomics is also acting as an additional catalyst for the growth of industrial players in this market. Dynamics of protein research, increasing investments in proteomics by biotech and pharmaceutical companies, and rising prevalence of acquired immunodeficiency syndrome (AIDS) are expected to drive the growth of the industry over the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Automated Immunoblotting Processors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Bio-Techne
Merck
PerkinElmer
Gen Script Biotech
ATTO Corporation
Tecan
Life Technologies
Euroimmun
Precision Biosystems
Cytoskeleton
LI-COR Biosciences
Cytiva
Molecular Devices
Segment by Type
Dry Blotting Systems
Semi-Dry Blotting Systems
Others
Segment by Application
Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Research & Academic Institution
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Automated Immunoblotting Processors report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index1 Automated Immunoblotting Processors Market Overview
1.1 Product Definition
1.2 Automated Immunoblotting Processors Segment by Type
1.2.1 Global Automated Immunoblotting Processors Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Dry Blotting Systems
1.2.3 Semi-Dry Blotting Systems
1.2.4 Others
1.3 Automated Immunoblotting Processors Segment by Application
1.3.1 Global Automated Immunoblotting Processors Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Diagnostic Laboratories
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Research & Academic Institution
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Automated Immunoblotting Processors Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Automated Immunoblotting Processors Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Automated Immunoblotting Processors Production Estimates and Forecasts (2018-2029)
1.4.4 Global Automated Immunoblotting Processors Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Automated Immunoblotting Processors Production Market Share by Manufacturers (2018-2023)
2.2 Global Automated Immunoblotting Processors Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Automated Immunoblotting Processors, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Automated Immunoblotting Processors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Automated Immunoblotting Processors Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Automated Immunoblotting Processors, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Automated Immunoblotting Processors, Product Offered and Application
2.8 Global Key Manufacturers of Automated Immunoblotting Processors, Date of Enter into This Industry
2.9 Automated Immunoblotting Processors Market Competitive Situation and Trends
2.9.1 Automated Immunoblotting Processors Market Concentration Rate
2.9.2 Global 5 and 10 Largest Automated Immunoblotting Processors Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Automated Immunoblotting Processors Production by Region
3.1 Global Automated Immunoblotting Processors Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Automated Immunoblotting Processors Production Value by Region (2018-2029)
3.2.1 Global Automated Immunoblotting Processors Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Automated Immunoblotting Processors by Region (2024-2029)
3.3 Global Automated Immunoblotting Processors Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Automated Immunoblotting Processors Production by Region (2018-2029)
3.4.1 Global Automated Immunoblotting Processors Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Automated Immunoblotting Processors by Region (2024-2029)
3.5 Global Automated Immunoblotting Processors Market Price Analysis by Region (2018-2023)
3.6 Global Automated Immunoblotting Processors Production and Value, Year-over-Year Growth
3.6.1 North America Automated Immunoblotting Processors Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Automated Immunoblotting Processors Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Automated Immunoblotting Processors Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Automated Immunoblotting Processors Production Value Estimates and Forecasts (2018-2029)
4 Automated Immunoblotting Processors Consumption by Region
4.1 Global Automated Immunoblotting Processors Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Automated Immunoblotting Processors Consumption by Region (2018-2029)
4.2.1 Global Automated Immunoblotting Processors Consumption by Region (2018-2023)
4.2.2 Global Automated Immunoblotting Processors Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Automated Immunoblotting Processors Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Automated Immunoblotting Processors Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Automated Immunoblotting Processors Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Automated Immunoblotting Processors Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Automated Immunoblotting Processors Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Automated Immunoblotting Processors Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Automated Immunoblotting Processors Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Automated Immunoblotting Processors Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Automated Immunoblotting Processors Production by Type (2018-2029)
5.1.1 Global Automated Immunoblotting Processors Production by Type (2018-2023)
5.1.2 Global Automated Immunoblotting Processors Production by Type (2024-2029)
5.1.3 Global Automated Immunoblotting Processors Production Market Share by Type (2018-2029)
5.2 Global Automated Immunoblotting Processors Production Value by Type (2018-2029)
5.2.1 Global Automated Immunoblotting Processors Production Value by Type (2018-2023)
5.2.2 Global Automated Immunoblotting Processors Production Value by Type (2024-2029)
5.2.3 Global Automated Immunoblotting Processors Production Value Market Share by Type (2018-2029)
5.3 Global Automated Immunoblotting Processors Price by Type (2018-2029)
6 Segment by Application
6.1 Global Automated Immunoblotting Processors Production by Application (2018-2029)
6.1.1 Global Automated Immunoblotting Processors Production by Application (2018-2023)
6.1.2 Global Automated Immunoblotting Processors Production by Application (2024-2029)
6.1.3 Global Automated Immunoblotting Processors Production Market Share by Application (2018-2029)
6.2 Global Automated Immunoblotting Processors Production Value by Application (2018-2029)
6.2.1 Global Automated Immunoblotting Processors Production Value by Application (2018-2023)
6.2.2 Global Automated Immunoblotting Processors Production Value by Application (2024-2029)
6.2.3 Global Automated Immunoblotting Processors Production Value Market Share by Application (2018-2029)
6.3 Global Automated Immunoblotting Processors Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Bio-Rad Laboratories
7.1.1 Bio-Rad Laboratories Automated Immunoblotting Processors Corporation Information
7.1.2 Bio-Rad Laboratories Automated Immunoblotting Processors Product Portfolio
7.1.3 Bio-Rad Laboratories Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Bio-Rad Laboratories Main Business and Markets Served
7.1.5 Bio-Rad Laboratories Recent Developments/Updates
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Automated Immunoblotting Processors Corporation Information
7.2.2 Thermo Fisher Scientific Automated Immunoblotting Processors Product Portfolio
7.2.3 Thermo Fisher Scientific Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Thermo Fisher Scientific Main Business and Markets Served
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.3 Bio-Techne
7.3.1 Bio-Techne Automated Immunoblotting Processors Corporation Information
7.3.2 Bio-Techne Automated Immunoblotting Processors Product Portfolio
7.3.3 Bio-Techne Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Bio-Techne Main Business and Markets Served
7.3.5 Bio-Techne Recent Developments/Updates
7.4 Merck
7.4.1 Merck Automated Immunoblotting Processors Corporation Information
7.4.2 Merck Automated Immunoblotting Processors Product Portfolio
7.4.3 Merck Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Merck Main Business and Markets Served
7.4.5 Merck Recent Developments/Updates
7.5 PerkinElmer
7.5.1 PerkinElmer Automated Immunoblotting Processors Corporation Information
7.5.2 PerkinElmer Automated Immunoblotting Processors Product Portfolio
7.5.3 PerkinElmer Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.5.4 PerkinElmer Main Business and Markets Served
7.5.5 PerkinElmer Recent Developments/Updates
7.6 Gen Script Biotech
7.6.1 Gen Script Biotech Automated Immunoblotting Processors Corporation Information
7.6.2 Gen Script Biotech Automated Immunoblotting Processors Product Portfolio
7.6.3 Gen Script Biotech Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Gen Script Biotech Main Business and Markets Served
7.6.5 Gen Script Biotech Recent Developments/Updates
7.7 ATTO Corporation
7.7.1 ATTO Corporation Automated Immunoblotting Processors Corporation Information
7.7.2 ATTO Corporation Automated Immunoblotting Processors Product Portfolio
7.7.3 ATTO Corporation Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.7.4 ATTO Corporation Main Business and Markets Served
7.7.5 ATTO Corporation Recent Developments/Updates
7.8 Tecan
7.8.1 Tecan Automated Immunoblotting Processors Corporation Information
7.8.2 Tecan Automated Immunoblotting Processors Product Portfolio
7.8.3 Tecan Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Tecan Main Business and Markets Served
7.7.5 Tecan Recent Developments/Updates
7.9 Life Technologies
7.9.1 Life Technologies Automated Immunoblotting Processors Corporation Information
7.9.2 Life Technologies Automated Immunoblotting Processors Product Portfolio
7.9.3 Life Technologies Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Life Technologies Main Business and Markets Served
7.9.5 Life Technologies Recent Developments/Updates
7.10 Euroimmun
7.10.1 Euroimmun Automated Immunoblotting Processors Corporation Information
7.10.2 Euroimmun Automated Immunoblotting Processors Product Portfolio
7.10.3 Euroimmun Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Euroimmun Main Business and Markets Served
7.10.5 Euroimmun Recent Developments/Updates
7.11 Precision Biosystems
7.11.1 Precision Biosystems Automated Immunoblotting Processors Corporation Information
7.11.2 Precision Biosystems Automated Immunoblotting Processors Product Portfolio
7.11.3 Precision Biosystems Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Precision Biosystems Main Business and Markets Served
7.11.5 Precision Biosystems Recent Developments/Updates
7.12 Cytoskeleton
7.12.1 Cytoskeleton Automated Immunoblotting Processors Corporation Information
7.12.2 Cytoskeleton Automated Immunoblotting Processors Product Portfolio
7.12.3 Cytoskeleton Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Cytoskeleton Main Business and Markets Served
7.12.5 Cytoskeleton Recent Developments/Updates
7.13 LI-COR Biosciences
7.13.1 LI-COR Biosciences Automated Immunoblotting Processors Corporation Information
7.13.2 LI-COR Biosciences Automated Immunoblotting Processors Product Portfolio
7.13.3 LI-COR Biosciences Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.13.4 LI-COR Biosciences Main Business and Markets Served
7.13.5 LI-COR Biosciences Recent Developments/Updates
7.14 Cytiva
7.14.1 Cytiva Automated Immunoblotting Processors Corporation Information
7.14.2 Cytiva Automated Immunoblotting Processors Product Portfolio
7.14.3 Cytiva Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Cytiva Main Business and Markets Served
7.14.5 Cytiva Recent Developments/Updates
7.15 Molecular Devices
7.15.1 Molecular Devices Automated Immunoblotting Processors Corporation Information
7.15.2 Molecular Devices Automated Immunoblotting Processors Product Portfolio
7.15.3 Molecular Devices Automated Immunoblotting Processors Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Molecular Devices Main Business and Markets Served
7.15.5 Molecular Devices Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Automated Immunoblotting Processors Industry Chain Analysis
8.2 Automated Immunoblotting Processors Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Automated Immunoblotting Processors Production Mode & Process
8.4 Automated Immunoblotting Processors Sales and Marketing
8.4.1 Automated Immunoblotting Processors Sales Channels
8.4.2 Automated Immunoblotting Processors Distributors
8.5 Automated Immunoblotting Processors Customers
9 Automated Immunoblotting Processors Market Dynamics
9.1 Automated Immunoblotting Processors Industry Trends
9.2 Automated Immunoblotting Processors Market Drivers
9.3 Automated Immunoblotting Processors Market Challenges
9.4 Automated Immunoblotting Processors Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
